BusinessGeneral NewsIndustryInternationalUncategorized

Global Cluster Headache Drug Market Analysis and Value Forecast Snapshot by End-use Industry 2026 || Major Market Players – F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Novartis AG, Pfizer Inc, AstraZeneca

Market Analysis: Global Cluster Headache Drug Market

Global cluster headache drug market is expected to grow at a substantial CAGR of in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to the increasing prevalence of cluster headaches, growing geriatric population, development in the healthcare expenditure and the government support for the research & development for new and better treatment have fueled the market growth.

Key market players in the global cluster headaches market are F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Novartis AG, Pfizer Inc, AstraZeneca, Eli Lilly and Company, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, TrioxBio Inc, Aurobindo Pharma, Endo Pharmaceuticals Inc, WOCKHARDT, Shanghai Soho Yiming Pharmaceutical Co., Ltd, Chengdu Tiantaishan pharmaceutical Co.,Ltd,  electroCore, Inc, Autonomic Technologies, Inc, WINSTON PHARMACEUTICALS, Inc, CAPNIA, Inc and few others.

Get Sample Analysis of Global Market Information:

Market Definition: Global Cluster Headache Drug Market

Cluster headache is also known as Horton’s syndrome is characterized by a series of relatively short but severe pain on one side of the head every day for weeks or months at a time. Headaches occur in form of clusters which means bouts of frequent attacks which may last from weeks to months and followed by long periods of relief. Cluster headaches occur at the same time each year because of their seasonal nature. Symptoms include nasal discharge, redness of eyes and excessive tearing.

The prevalence rate of cluster headache is less than 1percent and mostly affects men. The attacks can begin at any age, although they usually occur between the ages of 20 and 40 years. The lifetime prevalence of cluster headache for adults of all ages was 124 per 100,000 or approximately 0.1 percent.

Market Drivers

  • Increasing prevalence of cluster headaches and migraine is driving the growth of this market
  • Increased television viewing and computer usage is also acting as a driver for the market
  • Growing geriatric population is propelling the market growth
  • Application of latest technologies in the health care industry can also act as a market driver

Market Restraints

  • Lack of awareness amongst people and healthcare providers about cluster headaches is hampering the market growth.
  • Increasing measure by government to lessen healthcare expenditure is also restricting the growth for the market
  • Unfavorable health care policies will also hamper the market growth

Segmentation: Global Cluster Headache Drug Market

By Types

  • Episodic
  • Chronic

By Mechanism of Action

  • Corticosteroids
  • Ergot alkaloids
  • Local Anesthetics
  • Calcium Channel Blockers
  • Triptans
  • Lithium Carbonate
  • Anti-Seizures

By Drugs Type

  • Fast-Acting Drugs
    • Sumatriptan
    • Dihydroergotamine
    • Octreotide
    • Lidocaine
  • Long-Term Drugs
    • VerapamilLithobid
    • Divalproex
  • Short-Term Drugs
    • Ergotamine
    • Prednisone

By Diagnosis

  • Neurological Examination
  • MRI
  • CT Scan

By Treatment

  • Medication
  • Surgery

By Route of Administration

  • Oral
  • Topical
  • Intravenous
  • Others

By End-Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • Italy
    • U.K.
    • France
    • Spain
    • Netherlands
    • Belgium
    • Switzerland
    • Turkey
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Rest of South America
  • Middle East & Africa
    • South Africa
    • Rest of Middle East & Africa

Get TOC of Full Report:

Key Developments in the Market:

  • In June 2019, Eli Lilly and Company received the US FDA approval for Emgality (Galcanezumab). This drug became the first drug to gain U.S. approval for decreasing the frequency of episodic cluster headache attacks. It belongs to a new class of drugs called CGRP inhibitors that are used to prevent migraines or reduce their frequency
  • In April 2017, electroCore, Inc received the US FDA approval for gammaCore device, a non-invasive vagus nerve stimulator aimed to treat pain associated with episodic cluster headache in adult patients. Gammacore the first and only FDA-approved device for the prevention of cluster headache. It is a safe and effective treatment when compared to other treatments

Competitive Analysis:

Global cluster headaches drug market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of cluster headaches drug market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Research Methodology: Global Cluster Headaches Drug Market­

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technical Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global cluster headache drug market outlook in the developed and emerging markets.
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period.
  • The latest developments, market shares, and strategies that are employed by the major market players.

To Know More :

About Us

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing [email protected] . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475
Mail: [email protected]

Report Rating